chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Limited range for motion in left shoulder; Left shoulder weakness; Patient had concerns that the vaccination provider incorrectly administered the shot in his joint, instead of the deltoid muscle; Left shoulder pain; This spontaneous case was reported by a consumer and describes the occurrence of MOBILITY DECREASED (Limited range for motion in left shoulder), MUSCULAR WEAKNESS (Left shoulder weakness), INCORRECT ROUTE OF PRODUCT ADMINISTRATION (Patient had concerns that the vaccination provider incorrectly administered the shot in his joint, instead of the deltoid muscle) and ARTHRALGIA (Left shoulder pain) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032M20A and 004M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Mar-2021, the patient experienced MOBILITY DECREASED (Limited range for motion in left shoulder), MUSCULAR WEAKNESS (Left shoulder weakness), INCORRECT ROUTE OF PRODUCT ADMINISTRATION (Patient had concerns that the vaccination provider incorrectly administered the shot in his joint, instead of the deltoid muscle) and ARTHRALGIA (Left shoulder pain). At the time of the report, MOBILITY DECREASED (Limited range for motion in left shoulder), MUSCULAR WEAKNESS (Left shoulder weakness) and ARTHRALGIA (Left shoulder pain) had not resolved and INCORRECT ROUTE OF PRODUCT ADMINISTRATION (Patient had concerns that the vaccination provider incorrectly administered the shot in his joint, instead of the deltoid muscle) had resolved.            No concomitant medications were provided by the reporter No treatment information was provided by the reporter Patient reported that he might have shoulder injury related to vaccine administration SIRVA  It was reported that the patient experienced problems with his left shoulder at the time of report and scheduled for appointment with his doctor next week
Headache, Myalgia, Fever, Diarrhea, fatigue, injection site pain/arm pain Narrative:  Other Relevant History:
Patient had red area at site of injection. She said it felt hot, hard and some swelling. No itching was experienced. She was going to apply cold compresses.  She was at work and was to return so we could see if it helped. She did not return to pharmacy.
Estimated delivery date of August 5th, 2021. Currently 35 weeks. Development of preeclampsia, gestational diabetes at 34 weeks. 2 episodes of heavy vaginal bleeding during pregnancy, one at 30 weeks (just after 2nd dose of moderna vaccine) and one at 34 weeks. Currently being monitored for worsening preeclampsia with plans to deliver at 37 weeks (July 15, 2021) if stable. Gestational diabetes managed with diet and exercise at this time. Bleeding resolved within 2 or 3 days. Developed anemia after second bleeding episode.
Shortness of breath , chest pain , afib placed on blood thinner administered oxygen . Admitted to intensive care. Blood clots in both legs and both lungs
Initial information has been received from a licensed practical nurse concerns a 61 years old patient with an unspecified gender, pertinent medical history or drug reactions/allergies. On 11-JAN-2013, the patient was vaccinated subcutaneously with 0.5 ml dose of (Merck) PROQUAD (lot# H015642 exp date 06-JAN-2014) instead of (Merck) ZOSTAVAX. No other co-suspects were reported. No concomitant medications were reported. No adverse effects were reported. No treatment information was reported. The patient's outcome was unknown. This is one of several reports from the same source. Additional information has been requested.
Erythema left thigh, SX started 9/7/06. Benadryl given.
Subjective  Patient is a 23-year-old obese female who received the Pfizer vaccine in March of this year but tested positive for Covid 1 week ago she comes in today very anxious breathing about 30 times a minute stating that she cannot catch her breath but her oxygen saturation was 100%. She received the Regeneron infusion yesterday-states she was feeling worse today she also complains of some chest pain with her breathing. States she has had cough which has been dry she denies fever in the last 24 hours-she rates her pain a 6/10  Review of Systems  Constitutional: Negative for chills, fatigue and fever.  HENT: Negative for congestion, tinnitus and trouble swallowing.  Eyes: Negative for photophobia, discharge and redness.  Respiratory: Positive for cough and shortness of breath.  Cardiovascular: Positive for chest pain. Negative for palpitations.  Gastrointestinal: Negative for abdominal pain, diarrhea, nausea and vomiting.  Genitourinary: Negative for dysuria, frequency and urgency.  Musculoskeletal: Negative for back pain, joint swelling and myalgias.  Skin: Negative for rash.  Neurological: Negative for dizziness and headaches.  Psychiatric/Behavioral: Negative for confusion. The patient is nervous/anxious.  All other systems reviewed and are negative.
Ringworm on my face. Topical cream not effective. Now on oral medication. Influenza vaccine received on 11/03/2021.
Patient developed autoimmune hepatitis diagnosed in early December 2020 approximately 6 weeks after vaccination
Patient hyperventilated after vaccination, pt experienced brief period of unconsciousness/unaware of surroundings. After 1 to 2 minutes patient came around and began to cry paramedics were called vital checks pt okay.
pt recv three doses of vax, for prophylaxis; w/in 12 hr exp fever and vomiting; vax not related to illness; no further info avail; sxs continue
At 10:52 am patient stood up to schedule her second dose appointment because she stated she did not have the appointment yet. She was up front with the PCT, when this NP was called to come to the front because the patient had passed out and hit her head. EMS was called. Upon coming up to the patient, the patient was conscious. Examined patient for head or neck injuries. She denied any neck pain but stated the back of her head hurt. patient placed into chair with assistance, and given a bottle of water and an icepack. Upon inspection, patient had no lacerations or bleeding from the head. A 4 cm "goose egg" was noted to the back of the head. Neuro exam was normal. Patient alert and oriented times 4. Stated vision got blurry prior to passing out, however it was normal at the time of the exam. noted. Patient refused EMS transport at time of arrival 11:08 am. patient refused to go to ER. AMA form signed. Patient educated on signs and symptoms that mean she should seek immediate medical attention. Patient verbalized understanding of these teachings.
Information has been received from a registered nurse concerning a female who on 30-OCT-2007 was vaccinated intramuscularly with a 0.5 mL dose of pneumococcal 23v polysaccharide vaccine, (lot # "0099U"). Concomitantly the patient was vaccinated with influenza virus vaccine (unspecified). The patient received the influenza virus vaccine (unspecified) and the pneumococcal 23v polysaccharide vaccine in one arm each. It was reported that the patient experienced soreness and pain in her arm, but not at the injection site, with a rash or redness of the blood vessels of her hands and wrists. She was treated with ibuprofen and ice. It was not known if the patient had received pneumococcal 23v polysaccharide vaccine in the past. It was reported that a total of 45 persons who worked together were vaccinated during a vaccine clinic at their company. All patients received the influenza virus vaccine (unspecified) and 12 persons received the pneumococcal 23v polysaccharide vaccine. There have been no adverse symptoms reported. The nurse reported that two other patients had adverse events after receiving the pneumococcal 23v polysaccharide vaccine. (WAES #0711USA00610 and WAES # 0711USA02460). In follow-up the registered nurse stated that the problem that the patient had did not have anything to do with the vaccine. She stated that it was a coincidence that the "two events" occurred in the "shot" time frame. Additional information is not expected.
knot under her skin; a lump in her chest and that spot is red; a lump in her chest and that spot is red; This is a spontaneous report from a contactable consumer (patient). A 63-year-old female patient received bnt162b2 (PFIZER BIONTECH COVID mRNA VACCINE, solution for injection, Lot Number: EW0162, Expiry Date: Unknown), via an unspecified route of administration, administered in arm Left on 14Apr2021 at 13: 00 (at the age of 63-year-old) as single dose for covid-19 immunization. The patient medical history included COVID (a year ago she had got COVID), and she had no allergic reaction, the patient's concomitant medications were not reported. Patient stated that when it came out a year ago, she had got COVID so that is why she took the vaccine this year. She took her first dose of the Pfizer Covid-19 vaccine yesterday and about 4 to 5 hours later she noticed a knot under her skin on her chest with a red area and at 18: 00 to 19: 00 when she was at work, she got a reaction which was a lump in her chest and that spot was red. She probed if the lump was still there, and she stated that she went to bed with it and she woke up with it that's why she was called. She wanted to know what it was. Patient stated that her second dose is scheduled for 08May2021. On an unspecified date, 5 hours later of vaccination, the patient experienced knot under her skin, a lump in her chest and that spot is red, a lump in her chest and that spot is red. The outcome of the event was not recovered.  No follow-up attempts are needed. No further information is expected.
Joint pain; Slight headache; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), on 10Oct2023 as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ARTHRALGIA (non-serious) with onset 11Oct2023, outcome "unknown", described as "Joint pain"; HEADACHE (non-serious) with onset 11Oct2023, outcome "unknown", described as "Slight headache".  The information on the batch/lot number for bnt162b2 omi xbb.1.5 has been requested and will be submitted if and when received.
- Random rashes all body parts but the palm of the hands.  - Rashes last between 10 minutes to 2 hours - Rashes itch and the itching subsides with Benadryl - Benadryl does seem to impact the duration of the rash - Kept a solid diary of foods eaten and detergent utilized - Not showering for a week did not reduce the onset of rashes - Not wearing a shirt for a day did not reduce the onset of rashes on the upper body - Exposing the legs to no clothing did not reduce the onset of rashes - Sweating or not sweating did not change the rash onset or location - Rashes sometimes occur in the middle of the night and other nights no rash
Local swelling, erythema & tenderness in deltoid - administration site - onset day after.
Weakness, nausea, light sensitivity, headaches, and sleepiness occurred within 5 minutes of vaccine administration. This advanced to full body muscle and joint pain and daily migraines. Fatigue, sleepiness, nerve pain and migraines persist. Medication for migraines had to be prescribed. Migraines continue to be experienced at least 4 days each week. Nerve pain in lower back, hips and left leg continue as well.
Patient DOB: 9/29/2007. Received her first dose of Pfizer (LOT#: EW0161 Exp: 8/2021) at 1144 on 6/08/21. PHN noticed patients eyes rolling back. PHN got up and asked mother of patient if patient was okay. Mother stated that patient was feeling dizzy and that she had not eaten breakfast. PHN assessed patient. Patient was pale and diaphoretic. PHN asked patient if she had anything to eat before getting vaccinated. Patient stated she did not eat breakfast. PHN gave patient a snack and juice to drink. Patient finished snack and juice. EMT  took patient vital signs. BP: 100/64, pulse: 82, O2: 97%. At 1158 patient stated that she was feeling better. Patient was no longer dizzy and was not diaphoretic or pale. Patient was moved to zero gravity chair. EMT retook vital signs and reassessed patient at 1215. BP: 100/60, pulse: 80, O2: 99%. Patient stated that she no longer felt any symptoms. EMT retook vital signs and reassessed patient at 1225. BP: 100/64, pulse: 73, O2: 97%. Patient stated that she did not feel any symptoms. Patient was educated on worsening signs and symptoms of side effects of the vaccine and when to call EMS or go to the ED/urgent care. Patient left with her mom unassisted and with a steady gait.
11/19/2022 In the morning Sore and scratchy throat.  Nasal Congestion got worse through the day.  Chills and felt hot, temperature regulation issue and headache.  11/20, symptoms continued, and I got a fever, peaking at 100, with fatigue.  11/21 Symptoms continued through 11/22 when I developed a wheeze with tightness in the throat.  Consulted with MD, who prescribed a steroid.  Got a PCR test on 11/21, positive.  11/22 MD consulted, prescribed Albuterol and Prednisone.   Advised to treat symptomatically.  Felt Better 11/26.  Returned to work on 11/28, only had lingering congestion through 11/29.  Symptoms cleared up on 11/30.
The patient is 63 and Fluad quadrivalent is indicated for over age 65. The patient did not show any reaction signs at time of administration and today 8/31/2020 she patient states that she had no Adverse reaction whatsoever. She had a runny nose and mucus for a couple of days after the vaccine but it was nothing out of the ordinary.  Patient states she feels her normal self and aside from her chihuahua bumping into her arm she has felt no pain. She says when her chihuahua sits on her feet they hurt but that is true every day of her life
pt developed low grade fever  99 for 2 days along with inflamation size of palm of ones hand.    c/o hard lump at center of inflamation. and continues to be sore.  pt states inflamation {reddness decreased but still sore  }
I didn't get the second Moderna vaccine for 5 weeks; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (I didn't get the second Moderna vaccine for 5 weeks) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-May-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (I didn't get the second Moderna vaccine for 5 weeks). On 28-May-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (I didn't get the second Moderna vaccine for 5 weeks) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided. Treatment information was not provided.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Reporter did not allow further contact
I have had a sore throat for 3 months since soon after the vaccine including general redness and a large sore that did not heal for about 2 months.  I saw a Dr. who thought it might be an autoimmune issue potentially and then it occurred to me that it might be related to the vaccines.  In addition to the two vaccines that I received on November 3 (COVID booster and seasonal flu) I had received two additional COVID vaccines this year in January and Feb and a Zoster vaccine in July making a total of 5 vaccine shots in 10 months. Not sure if that is related to possible autoimmune symptoms, which I have no prior history of.
AXILLARY LYMPH NODE SWELLING, PAIN IN ARM, JOINT PAIN, ELBOW PAIN, THUMB SWELLING, WEAKNESS, BODYACHES, POST NASAL DRIP, HEADACHE, CHILLS, SINUS CONGESTION, FATIGUE. ASTHMA EXACERBATION Narrative:
Armpit/ lymph node under left arm is tender and swollen. Armpit has no indentation whether arm is down or lifted. Lymph node feels tender at the touch of the arm being in lowered position. Swelling extends out from and around armpit area.
Information has been received from a registered nurse concerning a patient who was vaccinated with Gardasil vaccine. Subsequently, the patient experience syncope. Additional information has been requested. It was reported that another patient experienced syncope after Gardasil vaccination (WAES0711USA00034).
RASH DEVELOPED 3 DAYS AFTER VACCINATION , RASH COVERED BACK, TORSO.
The patient came in for the 1st Moderna vaccine but instead he received bi-valent Moderna booster.  After we realized our mistake we gave him 1st Moderna vaccination. Customer had to have it because he needed that to be admitted to rehab.
Patient's mother called our office on 12/14/11 stating that patient's (L) thigh was red & swollen 3x larger than normal & fever 103-104 degrees. Has been giving TYLENOL p.o. Fever responds well. Has been using cold compresses to leg. 12/15/11 mother states thigh is normal size, no fever.
Hard time swallowing,swallowing issues is ongoing; blood pressure getting higher and higher; panting for air; heart racing; Thirsty; easily out of breath; rednes to right arm (opposite arm form vaccination); rash to right arm (opposite arm from vaccination); extremely tired (taking 3 hour naps per day); This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DYSPHAGIA (Hard time swallowing,swallowing issues is ongoing), HYPERTENSION (blood pressure getting higher and higher), RESPIRATORY RATE INCREASED (panting for air) and PALPITATIONS (heart racing) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included MOMETASONE FUROATE (FLONASE [MOMETASONE FUROATE]), MULTIVITAMIN [VITAMINS NOS] and PROBIOTICS NOS for an unknown indication.    On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Mar-2021, the patient experienced DYSPHAGIA (Hard time swallowing,swallowing issues is ongoing) (seriousness criteria medically significant and life threatening). 29-Mar-2021, the patient experienced HYPERTENSION (blood pressure getting higher and higher) (seriousness criteria medically significant and life threatening), RESPIRATORY RATE INCREASED (panting for air) (seriousness criteria medically significant and life threatening), PALPITATIONS (heart racing) (seriousness criterion medically significant), THIRST (Thirsty), DYSPNOEA (easily out of breath), ERYTHEMA (rednes to right arm (opposite arm form vaccination)), RASH (rash to right arm (opposite arm from vaccination)) and FATIGUE (extremely tired (taking 3 hour naps per day)). On 29-Mar-2021, DYSPHAGIA (Hard time swallowing,swallowing issues is ongoing), HYPERTENSION (blood pressure getting higher and higher), RESPIRATORY RATE INCREASED (panting for air), PALPITATIONS (heart racing), THIRST (Thirsty) and ERYTHEMA (rednes to right arm (opposite arm form vaccination)) had resolved. On 01-Apr-2021, RASH (rash to right arm (opposite arm from vaccination)) had resolved. At the time of the report, DYSPNOEA (easily out of breath) and FATIGUE (extremely tired (taking 3 hour naps per day)) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment: The patient received epinephrine (Epi pen) on 29/Mar/2021.; Sender's Comments: This case concerns a 46-year-old female with serious unexpected events of dysphagia, hypertension, respiratory rate increased, palpitations, and nonserious unexpected dyspnea, thirst and expected rash, fatigue. Event onset 2 minutes after first dose mRNA-1273. Events resolved, but outcomes for dyspnea and fatigue unknown. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
I had a headache and my throat was sore and I felt fatigued.  During the day I started coughing a lot that day and that was on a Sunday and my husband and I was driving home and got home and took a home COVID-19 test and it was negative and realized the test was expired.  The next day I took another home COVID-19 test that was not expired and that one was positive.  I went and took a PCR test and that one was positive at the urgent care clinic.   They prescribed me Paxlovid to take for 5 days.   My symptoms are very mild at this point and feeling much better.
pt recvd Engerix-B & 5JUL92 had sudden chest discomfort, coughing, & abdo discomfort; lasted approx 2 wks; pt contacted by MD; dx w/bronchitis;
I had pain that got much more pronounced in my arm where I had the shot. The pain started to propagate to my back and head. Then I got very cold and started shivering till I took ibuprofen and got in a warm bath. Felt okay in the morning. This was second dose. Had the first shot in mid September. Had terrible back pain 5 weeks after first shot. Not sure if the back pain is related to the shot but never had anything like that in the past. Pain 5 weeks after first shot started in left shoulder and was in arm and chest. Checked for heart attack but doctor thought pinched nerve. Pain lasted 4-6 weeks. Had second shot in right shoulder to see if I would get similar pain on right side after this shot.
Facial and Neck Flushing, Shaking Chills, Involuntary Leg Movement, Increasing Blood Pressure topping out at 198/101
Patient developed Guillain-Barre syndrome 2 weeks after influenza vaccination. Required incubation, prolonged hospital course. Discharged to rehabilitation facility.
She said she felt faint, we had her sit down, take off her jacket and drink water. She slumped over, eyes rolled back and started shaking. It appeared she had a seizure. Called 911. Laid her down on the floor and she was responsive and talking in a couple of minutes. BP and blood ox was normal when EMTs arrived. Pt refused trip to hospital.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 40-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 23Mar2021 as dose 1, single (Batch/Lot number: unknown), in right arm, on 15Apr2021 as dose 2, single (Batch/Lot number: unknown), in right arm and on 22Nov2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 39 years, in right arm for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: MELOXICAM, start date: 17Jun2022. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of vaccination failure, covid-19.  Clinical course: Multivitamin other medication in 2 weeks brand Megafood. Covid "rebound" of symptoms 5 days after completing Paxlovid prescription.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.